Literature DB >> 19636212

Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.

L Sun1, H Lv, W Wei, D Zhang, Y Guan.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a main cause of infertility, particularly in high-risk settings such as spontaneous abortions (SAB). We aimed to evaluate the effect of genetic polymorphisms in ACE and plasminogen activator inhibitor-1 (PAI-1) on the occurrence of SAB in PCOS.
METHODS: One hundred and forty-two PCOS patients (83 women have a history of one or more unexplained SAB, 59 women have successfully live births) and 107 healthy controls matched for age and body mass index were included in the study. Levels of PAI-1, LH, FSH, testosterone, fasting glucose and insulin were measured. ACE deletion (D)/insertion (I) and PAI-1 4G/5G gene polymorphisms were performed.
RESULTS: The D/D and/or 4G/4G genotype frequency, the D or 4G allelic frequency, the combination of the ACE D/D and PAI-1 4G/5G, D/I and 4G/4G genotypes of PCOS patients with SAB women were statistically higher than non-SAB group (p<0.05). The 4G/4G or D/D genotype of PCOS with SAB patients had significantly higher PAI-1 levels than non-SAB women.
CONCLUSIONS: The ACE D/I and PAI-1 4G/5G gene polymorphisms might represent risk factor in PCOS with SAB. Homozygosity for ACE D or PAI-1 4G polymorphisms as well as compound carrier status are significant positive explanatory variable for PCOS patients with SAB, which may result in increased PAI-1 concentrations and hypofibrinolysis and contribute to early pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636212     DOI: 10.1007/BF03346557

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

Review 1.  Plasminogen-activator inhibitor type 1 and coronary artery disease.

Authors:  H P Kohler; P J Grant
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  Polycystic ovarian syndrome and thrombophilia.

Authors:  G Tsanadis; G Vartholomatos; I Korkontzelos; F Avgoustatos; G Kakosimos; A Sotiriadis; A Tatsioni; A Eleftheriou; D Lolis
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

3.  Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.

Authors:  D K Kim; J W Kim; S Kim; H C Gwon; J C Ryu; J E Huh; J A Choo; Y Choi; C H Rhee; W R Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

4.  Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility.

Authors:  C Fatini; F Gensini; B Battaglini; D Prisco; A P Cellai; S Fedi; R Marcucci; T Brunelli; G Mello; E Parretti; G Pepe; R Abbate
Journal:  Blood Coagul Fibrinolysis       Date:  2000-10       Impact factor: 1.276

5.  Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome.

Authors:  Burak Hacihanefioglu; Asli Somunkiran; Ismet Mahmutoglu; Alper Sercelik; Semra Toptani; Ertan Kervancioglu
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

Review 6.  The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.

Authors:  Julian H Barth; Ephia Yasmin; Adam H Balen
Journal:  Clin Endocrinol (Oxf)       Date:  2007-08-29       Impact factor: 3.478

7.  Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.

Authors:  Dora Fabbro; Angela V D'Elia; Riccardo Spizzo; Lorenza Driul; Giovanni Barillari; Carla Di Loreto; Diego Marchesoni; Giuseppe Damante
Journal:  Gynecol Obstet Invest       Date:  2003-07-14       Impact factor: 2.031

8.  Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.

Authors:  Charles J Glueck; Luann Sieve; Binghua Zhu; Ping Wang
Journal:  Metabolism       Date:  2006-03       Impact factor: 8.694

9.  Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.

Authors:  Astrid Dossenbach-Glaninger; Michael van Trotsenburg; Martin Dossenbach; Christian Oberkanins; Anne Moritz; Walter Krugluger; Johannes Huber; Pierre Hopmeier
Journal:  Clin Chem       Date:  2003-07       Impact factor: 8.327

10.  Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages.

Authors:  T Buchholz; P Lohse; N Rogenhofer; E Kosian; R Pihusch; C J Thaler
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

View more
  11 in total

1.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

2.  The interaction effect of angiogenesis and endothelial dysfunction-related gene variants increases the susceptibility of recurrent pregnancy loss.

Authors:  E A Trifonova; M G Swarovskaya; O A Ganzha; O V Voronkova; T V Gabidulina; V A Stepanov
Journal:  J Assist Reprod Genet       Date:  2019-01-24       Impact factor: 3.412

3.  Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure.

Authors:  Farhad Khosravi; Saeed Zarei; Negah Ahmadvand; Zahra Akbarzadeh-Pasha; Elham Savadi; Amir-Hassan Zarnani; Mohammad-Reza Sadeghi; Mahmood Jeddi-Tehrani
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412

4.  Full trisomy 5 in a sample of spontaneous abortion and Arias Stella reaction.

Authors:  Vida Čulić; Bernarda Lozic; Ivana Kuzmić-Prusac; Goran Mijaljica; Jasminka Pavelić
Journal:  Med Sci Monit       Date:  2011-10

5.  Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.

Authors:  Xuejiao Li; Yukun Liu; Rui Zhang; Jianping Tan; Libin Chen; Yinglin Liu
Journal:  Med Sci Monit       Date:  2015-04-11

6.  High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis.

Authors:  Yi-Fei Sun; Jie Zhang; Yue-Ming Xu; Zi-Yu Cao; Yi-Zhuo Wang; Gui-Min Hao; Bu-Lang Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-03       Impact factor: 5.555

7.  The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS-A Long-Term Follow-Up Study.

Authors:  Małgorzata Jacewicz-Święcka; Sławomir Wołczyński; Irina Kowalska
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

8.  Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.

Authors:  Pratip Chakraborty; S K Goswami; Shweta Rajani; Sunita Sharma; Syed N Kabir; Baidyanath Chakravarty; Kuladip Jana
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  PCOSDB: PolyCystic Ovary Syndrome Database for manually curated disease associated genes.

Authors:  Maniraja Jesintha Mary; Umashankar Vetrivel; Deecaraman Munuswamy; Vijayalakshmi Melanathuru
Journal:  Bioinformation       Date:  2016-01-31

10.  Multiple dietary fiber for gestational hyperinsulinism: A protocol of systematic review and meta-analysis of randomized clinical trials.

Authors:  Botong Yang; Mengzhu Wu; Xinxia Zhang; Jia Xia; Lizhen Wang; Q I Chen; Min Zhong; Xiaoming Tang
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.